We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Stem Cell Therapy for Arterial Restenosis: Potential Parameters Contributing to the Success of Bone Marrow-Derived Mesenchymal Stromal Cells.
- Authors
Forte, Amalia; Rinaldi, Barbara; Sodano, Loredana; Berrino, Liberato; Rossi, Francesco; Finicelli, Mauro; Grossi, Mario; Cobellis, Gilda; Botti, Chiara; Feo, Marisa; Santè, Pasquale; Galderisi, Umberto; Cipollaro, Marilena
- Abstract
Purpose: Restenosis is a complex and heterogeneous pathophysiological phenomenon occurring in patients submitted to revascularization procedures. Previous studies proved the antirestenotic properties of injected allogenic mesenchymal stromal cells (MSCs) in an experimental model of rat carotid (re)stenosis induced through arteriotomy. In this study we describe some of the effects subsequent to MSC treatment of rats submitted to carotid arteriotomy and possibly responsible for their antirestenotic effect. Methods: Rat MSCs were isolated from bone marrow, expanded in vitro and characterized. Subsequently, we evaluated the effects of MSC administration via tail vein at 3 and 7 days after carotid arteriotomy both in rat serum and in injured carotids, focusing on DNA oxidative damage (8-oxo-dG detection), cell proliferation index (BrdU incorporation assay), apoptotic index (TUNEL assay), the expression of inflammation- and proliferation-related genes (RT-PCR), the release of growth factors and of inflammation-related cytokines (antibody arrays and ELISA). Results: MSC administration induced a greater cell proliferation in carotids after arteriotomy, together with an increased level of VEGF in the serum and with the higher expression of VEGF mRNA in injured carotids. Serum analysis also revealed a decreased level of the pro-inflammatory cytokines CXCL1, CXCL5, L-Selectin, ICAM-1 and LIX, and of TIMP1 and SDF-1alpha in MSC-treated rats. The MSC immunomodulatory activity was confirmed by the decreased expression of TLR2 and TLR4 in injured carotids. Conclusions: MSCs play an immunomodulatory paracrine role when injected in rats submitted to carotid arteriotomy, accompanied by the release of VEGF, possibly contributing to the accelerated repair of the injured vascular wall.
- Subjects
CORONARY restenosis; REVASCULARIZATION (Surgery); MESENCHYMAL stem cells; PARACRINE mechanisms; VASCULAR endothelial growth factors; CAROTID artery
- Publication
Cardiovascular Drugs & Therapy, 2012, Vol 26, Issue 1, p9
- ISSN
0920-3206
- Publication type
Article
- DOI
10.1007/s10557-011-6359-8